Hindson Benjamin J. 的 Form 4 申報

10x Genomics, Inc.（TXG），2021/9/3 申報

申報編號: 0001209191-21-054899
申報時間: 2021/9/3
交易日: 2021/9/1
申報延遲: 2 天
10b5-1 計畫: 表單沒有這欄（2023 年以前）

SEC EDGAR 原文（在新分頁開啟）

這份申報列了 7 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $739.6 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人	與公司的關係
Hindson Benjamin J.CIK 0001786391	董事、高階主管（見申報備註）

非衍生性證券（表 I）

普通股等股票的取得與處分，每一列是申報上的一筆。

非衍生性證券的交易
交易日	證券	交易	股數	價格	金額	交易後持股	持有方式
2021/9/1	Class A Common Stock	M行使選擇權取得	+41,666	$5.04	+$209,996.64	88,783	直接
2021/9/1	Class A Common Stock	S賣出處分	−1,049	$174.39^F2	−$182,935.11	87,734	直接
2021/9/1	Class A Common Stock	S賣出處分	−2,728	$175.69^F3	−$479,282.32	85,006	直接
2021/9/1	Class A Common Stock	S賣出處分	−7,530	$176.65^F4	−$1,330,174.5	77,476	直接
2021/9/1	Class A Common Stock	S賣出處分	−21,145	$177.72^F5	−$3,757,889.4	56,331	直接
2021/9/1	Class A Common Stock	S賣出處分	−8,586	$178.56^F6	−$1,533,116.16	47,745	直接
2021/9/1	Class A Common Stock	S賣出處分	−628	$179.20^F7	−$112,537.6	47,117	直接

衍生性證券（表 II）

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日	證券	交易	標的股數	單價	金額	交易後持有	持有方式	旗標
2021/9/1	Class A Common Stock	M行使選擇權處分	−41,666	$0.00	$0	102,782	直接

附註與備註

本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。

This transaction was executed in multiple trades at prices ranging from $174.14 to $175.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

This transaction was executed in multiple trades at prices ranging from $175.14 to $176.135. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

This transaction was executed in multiple trades at prices ranging from $176.14 to $177.12. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

This transaction was executed in multiple trades at prices ranging from $177.14 to $178.13. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

This transaction was executed in multiple trades at prices ranging from $178.14 to $179.13. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

This transaction was executed in multiple trades at prices ranging from $179.14 to $179.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

備註

Chief Scientific Officer and President

看 SEC EDGAR 上的完整原文（在新分頁開啟）